Concepedia

Author

Jacqueline Doody

Memorial Sloan Kettering Cancer Center

Also Known As

J Doody, J. Doody, Jacqueline Doody, Jacqueline F Doody, Jacqueline F. Doody

58

Publications

7.9K

Citations

26

H-Index

64

Concepts

All Affiliations

Memorial Sloan Kettering Cancer CenterHoward Hughes Medical InstituteSciClone Pharmaceuticals (United States)F-star (United Kingdom)Duke Medical Center
JD

About

Jacqueline Doody is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, cell biology, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

21

24

6.5K

2

Cell Biology

14

14

6.1K

3

Natural Sciences

5

5

842

4

Biomolecular Engineering

4

4

826

5

Biochemistry

2

2

70

Jacqueline Doody

×

30

Publications

7.9K

Citations

26

H-Index

YearCitations

TGFβ signals through a heteromeric protein kinase receptor complex

Jeffrey L. Wrana, Liliana Attisano, Juan M. Cárcamo,

Cell

1992

1.5K

A mechanism of repression of TGFbeta / Smad signaling by oncogenic Ras

Marcus Kretzschmar, Jacqueline Doody, Inna Timokhina,

Genes & Development

1999

997

Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1

Marcus Kretzschmar, Jacqueline Doody, Joan Massagu�

Nature

1997

870

Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway

Luis Ulloa, Jacqueline Doody, Joan Massagué

Nature

1999

808

Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system

Fernando López‐Casillas, Sela Cheifetz, Jacqueline Doody,

Cell

1991

683

A human Mad protein acting as a BMP-regulated transcriptional activator

Fang Liu, Akiko Hata, Julie C. Baker,

Nature

1996

674

Human Type II Receptor for Bone Morphogenic Proteins (BMPs): Extension of the Two-Kinase Receptor Model to the BMPs

Fang Liu, Francesc Ventura, Jacqueline Doody,

Molecular and Cellular Biology

1995

600

The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase.

Marcus Kretzschmar, F Liu, Akiko Hata,

Genes & Development

1997

571

Anti–Transforming Growth Factor β Receptor II Antibody Has Therapeutic Efficacy against Primary Tumor Growth and Metastasis through Multieffects on Cancer, Stroma, and Immune Cells

Zhaojing Zhong, Kyla Driscoll Carroll, Desiree Policarpio,

Clinical Cancer Research

2010

122

Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.

Fang Liao, Jacqueline Doody, Jay Overholser,

PubMed

2002

106

Page 1